CROUSE HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1887-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.crouse.org/
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
Not Applicable
Recruiting
- Conditions
- Poor Growth in Extremely Preterm InfantsNecrotizing Enterocolitis
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2023-02-13
- Lead Sponsor
- Crouse Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04284280
- Locations
- 🇺🇸
Crouse Hospital, Syracuse, New York, United States
Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU
Phase 2
Completed
- Conditions
- Staphylococcus
- Interventions
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Crouse Hospital
- Target Recruit Count
- 216
- Registration Number
- NCT02967432
- Locations
- 🇺🇸
Crouse Hospital - Neonatal Intensive Care Unit, Syracuse, New York, United States
News
No news found